Biosynth News and Resources

CDMO News

Biosynth Opens Expanded GMP Bioconjugation Facility in Berlin

Biosynth has officially opened its expanded GMP bioconjugation facility in Berlin, further strengthening its global manufacturing network and CDMO services. The upgrade enhances production of conjugate vaccines and drugs, activated PEGs, and polymer-based excipients used in drug delivery. The expansion includes

Read More »

Biosynth

Biosynth is a Distributor/Import Export, Manufacturer/Innovator, Academic/Research, Contract Service, CMO/CDMO, Contract Research Organisation (CRO) company operating in the pharmaceutical industry. Securing Life Sciences Supply Chains – where Chemistry meets Biology, Products meet Services and Innovation meets Quality, Biosynth is at

Read More »
Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.